Biomedicine

Abstract

The administration of cytotoxic substances in cancer therapy leads to profound nausea and vomiting, hence impeding the progress of cancer treatment. Cancer radiation therapy is also known to induce nausea and vomiting. An inconvenient symptom would impede therapy and diminish the overall quality of life, causing anxiety and hopelessness and rendering everyday activities challenging When used together with dexamethasone, 5-HT3 receptor antagonists are highly efficient in reducing acute vomiting caused by cisplatin and mildly emetogenic therapy. Further research is required to gain a deeper understanding of the occurrence of CINV (Chemotherapy induced nausea and vomiting) in relation to new chemotherapies, particularly those taken orally on a daily basis. Determining the best combinations and timing of their administration in situations where chemotherapy is given over multiple days is important and the findings will greatly benefit patients by reducing treatment dropout rates and facilitating adherence to their chemotherapy regimens.